Dec-17-20 Initiated
ROTH Capital
Buy
$107
Aug-22-19 Initiated
Jefferies
Hold
$65
Apr-16-19 Initiated
Tigress Financial
Buy
Oct-25-18 Upgrade
Sidoti
Neutral → Buy
Oct-24-18 Upgrade
Pivotal Research Group
Hold → Buy
$135
Apr-23-18 Downgrade
Pivotal Research Group
Buy → Hold
$95 → $95
Feb-07-18 Reiterated
Pivotal Research Group
Buy
$80 → $95
Jan-24-18 Downgrade
Sidoti
Buy → Neutral
Oct-25-17 Reiterated
Pivotal Research Group
Buy
$70 → $80
Jul-26-17 Reiterated
Pivotal Research Group
Buy
$75 → $70
May-03-17 Upgrade
Pivotal Research Group
Hold → Buy
$55 → $75
May-01-17 Downgrade
Pivotal Research Group
Buy → Hold
$55
Feb-08-17 Reiterated
Pivotal Research Group
Buy
$80 → $75
Jul-28-16 Reiterated
DA Davidson
Neutral
$135 → $150
Feb-10-16 Downgrade
DA Davidson
Buy → Neutral
$155 → $130
Oct-16-15 Upgrade
Sidoti
Neutral → Buy
Sep-16-15 Upgrade
DA Davidson
Neutral → Buy
$180 → $165
Aug-06-15 Downgrade
DA Davidson
Buy → Neutral
$165 → $180
Aug-05-15 Upgrade
Pivotal Research Group
Hold → Buy
$135 → $200
Jun-26-15 Initiated
DA Davidson
Buy
$165
Feb-25-21 09:56AM
Feb-16-21 04:17PM
Feb-12-21 09:32AM
Feb-11-21 11:40AM
07:40AM
Feb-10-21 04:30PM
10:02AM
Feb-09-21 06:25PM
05:21PM
04:17PM
Feb-08-21 10:13AM
Feb-02-21 12:31PM
07:07AM
Jan-17-21 04:20PM
Jan-15-21 04:21AM
Jan-06-21 12:00PM
Jan-05-21 09:12AM
Dec-30-20 09:23AM
Dec-29-20 02:54PM
Dec-28-20 01:17PM
Dec-23-20 09:13AM
Dec-18-20 03:36PM
Dec-16-20 10:07PM
04:21AM
Dec-03-20 11:00AM
Nov-27-20 09:45AM
Nov-17-20 02:29AM
Oct-28-20 08:45AM
Oct-26-20 02:53PM
Oct-23-20 11:30AM
Oct-22-20 01:49PM
Oct-21-20 02:00PM
Oct-20-20 05:49PM
05:35PM
04:29PM
04:17PM
Oct-19-20 10:21AM
Oct-13-20 12:30PM
12:28PM
Oct-09-20 07:02AM
Oct-05-20 01:45PM
Sep-30-20 09:00AM
Sep-28-20 03:45PM
02:00PM
Sep-24-20 08:25AM
Sep-23-20 11:58AM
Sep-22-20 06:55PM
Sep-14-20 03:37PM
Sep-08-20 04:40PM
Sep-03-20 09:00AM
Sep-02-20 07:07AM
Aug-24-20 03:06PM
Aug-17-20 02:18PM
11:30AM
Aug-10-20 01:07PM
12:17PM
Aug-05-20 09:48AM
Aug-03-20 06:43PM Investor's Business Daily
Jul-31-20 11:30AM
Jul-24-20 02:37PM
Jul-22-20 03:00PM
Jul-21-20 05:45PM
04:45PM
04:17PM
09:32AM
08:11AM
Jul-17-20 03:16PM
09:42AM
Jul-15-20 11:30AM
Jul-14-20 12:30PM
09:00AM
Jul-09-20 09:00AM
Jul-03-20 07:59AM
Jul-02-20 01:09PM
Jul-01-20 09:34AM
Jun-30-20 11:46PM
Jun-26-20 10:41AM
Jun-24-20 11:18AM
Jun-19-20 07:03AM
Jun-11-20 11:28AM
Jun-10-20 05:05PM
03:00PM Thomson Reuters StreetEvents
Jun-02-20 09:25AM
May-26-20 10:06AM
May-14-20 08:25AM
May-06-20 11:34AM
May-04-20 09:00AM
Apr-29-20 09:25AM
Apr-27-20 01:48PM
12:38PM
Apr-23-20 07:06PM Investor's Business Daily
Apr-21-20 05:45PM
04:17PM
Apr-20-20 01:10PM
09:16AM
Apr-14-20 01:32PM
12:30PM
Apr-01-20 11:53AM
08:20AM
Mar-20-20 06:50PM
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Guest Kevin C.E.O. Feb 25 Sale 95.00 550 52,250 0 Feb 25 08:01 PM Noot Walter Chief Operating Officer Feb 24 Option Exercise 62.20 3,571 222,116 3,571 Feb 25 08:02 PM Guest Kevin C.E.O. Feb 24 Option Exercise 63.02 3,669 231,220 13,065 Feb 25 08:01 PM Guest Kevin C.E.O. Feb 24 Sale 95.00 12,515 1,188,936 550 Feb 25 08:01 PM Noot Walter Chief Operating Officer Feb 24 Sale 94.51 3,571 337,479 0 Feb 25 08:02 PM Macuga Daniel A. Chief Communications Officer Feb 22 Sale 92.00 3,930 361,560 0 Feb 24 09:13 PM Noot Walter Chief Operating Officer Feb 19 Sale 92.00 3,148 289,616 0 Feb 22 06:12 PM Mulham David Mulham Chief Field Development Office Feb 18 Sale 91.00 3,145 286,195 11,453 Feb 22 06:12 PM FULLER GILBERT A Director Feb 16 Sale 91.54 426 38,995 0 Feb 16 05:20 PM Brown Jim President Feb 16 Sale 92.38 5,415 500,225 0 Feb 16 05:20 PM Brown Jim President Feb 12 Sale 84.20 824 69,381 5,415 Feb 16 05:20 PM Neidig Brent Chief Officer & MD of China Feb 12 Sale 90.78 2,044 185,561 0 Feb 16 05:19 PM Guest Kevin C.E.O. Feb 11 Option Exercise 63.02 1,854 116,839 11,250 Feb 16 05:19 PM Noot Walter Chief Operating Officer Feb 11 Option Exercise 62.20 1,916 119,175 5,064 Feb 16 05:18 PM IIEKKING G DOUG CFO Feb 11 Sale 95.02 3,728 354,235 1,403 Feb 16 05:19 PM WOOD TIMOTHY E Director Feb 11 Sale 93.58 852 79,731 0 Feb 12 05:55 PM Peng Feng Director Feb 11 Sale 94.61 852 80,606 755 Feb 12 05:54 PM Foukas Joshua Chief Legal Officer Feb 11 Sale 95.02 2,906 276,128 0 Feb 16 05:19 PM Noot Walter Chief Operating Officer Feb 11 Sale 95.38 1,916 182,748 3,148 Feb 16 05:18 PM Guest Kevin C.E.O. Feb 11 Sale 95.35 1,854 176,784 9,396 Feb 16 05:19 PM IIEKKING G DOUG CFO Nov 04 Sale 76.29 454 34,637 1,913 Nov 06 04:42 PM FULLER GILBERT A Director Oct 26 Sale 83.87 426 35,728 0 Oct 28 06:14 PM SINNOTT ROBERT A Chief Scientific Officer Oct 26 Sale 84.74 318 26,947 0 Oct 26 08:45 PM Noot Walter Chief Operating Officer Oct 26 Sale 84.74 351 29,744 0 Oct 27 07:01 PM Foukas Joshua Chief Legal Officer Oct 26 Sale 84.06 197 16,560 0 Oct 27 07:01 PM Neidig Brent Chief Officer & MD of China Oct 26 Sale 84.81 175 14,841 0 Oct 27 07:00 PM AUCIAUX ROBERT Director Oct 23 Sale 85.29 989 84,352 426 Oct 23 07:53 PM SINNOTT ROBERT A Chief Scientific Officer Oct 22 Option Exercise 65.48 6,043 395,696 6,043 Oct 26 08:45 PM SINNOTT ROBERT A Chief Scientific Officer Oct 22 Sale 82.00 6,043 495,526 0 Oct 26 08:45 PM Peng Feng Director Oct 22 Sale 82.81 330 27,327 1,181 Oct 23 07:54 PM WENTZ MYRON W 10% Owner Aug 21 Sale 80.00 600,000 48,000,000 8,485,743 Aug 24 02:12 PM Foukas Joshua Chief Legal Officer Aug 20 Sale 83.15 270 22,451 0 Aug 21 12:53 PM Neidig Brent Chief Officer & MD of China Aug 13 Sale 83.76 260 21,776 0 Aug 14 12:23 PM WOOD TIMOTHY E Director Jul 29 Sale 81.35 426 34,655 0 Jul 29 06:59 PM FULLER GILBERT A Director Jul 29 Sale 81.00 426 34,506 0 Jul 29 06:58 PM Guest Kevin C.E.O. Jun 01 Sale 85.02 7,637 649,305 1,454 Jun 01 07:19 PM Peng Feng Director May 29 Sale 83.66 658 55,047 659 Jun 01 07:19 PM Guest Kevin C.E.O. May 28 Sale 85.55 5,054 432,380 9,091 Jun 01 07:19 PM WENTZ MYRON W Director May 05 Sale 80.75 641,270 51,782,553 9,085,743 May 07 05:57 PM Noot Walter Chief Operating Officer Apr 29 Option Exercise 62.20 9,571 595,316 9,571 May 01 07:15 PM Noot Walter Chief Operating Officer Apr 29 Sale 88.77 9,571 849,575 0 May 01 07:15 PM WENTZ MYRON W Director Apr 29 Sale 86.43 8,730 754,534 9,727,013 Apr 30 05:02 PM Peng Feng Director Apr 28 Sale 83.95 282 23,672 1,317 Apr 29 05:13 PM Neidig Brent Chief Officer & MD of China Apr 27 Sale 84.75 1,831 155,174 0 Apr 29 05:13 PM Macuga Daniel A. Chief Communications Officer Apr 27 Sale 84.22 4,599 387,347 1,552 Apr 27 05:22 PM Brown Jim President Apr 24 Sale 83.66 8,027 671,508 2,178 Apr 27 05:24 PM FULLER GILBERT A Director Apr 24 Sale 83.86 329 27,590 0 Apr 27 05:22 PM SINNOTT ROBERT A Chief Scientific Officer Apr 24 Sale 83.00 2,874 238,542 0 Apr 27 05:23 PM Winssinger Frederic J Director Apr 23 Sale 82.45 1,099 90,607 500 Apr 27 05:23 PM Foukas Joshua Chief Legal Officer Apr 23 Sale 82.49 1,966 162,169 0 Apr 27 05:23 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite